Does Sanofi SA pay a dividend?

Yes, Sanofi SA pays a dividend. The current annual yield is 5.52%. This is for informational purposes only and does not constitute investment advice.

What is Sanofi SA's dividend yield?

Sanofi SA's current dividend yield is 5.52%. This is calculated from the trailing 12-month dividends divided by the current share price. This is for informational purposes only and does not constitute investment advice.

How often does Sanofi SA pay dividends?

Sanofi SA pays dividends on a final basis. This is for informational purposes only and does not constitute investment advice.

Is Sanofi SA's dividend safe?

Sanofi SA has a DividendAtlas Dividend Health Score of 85 out of 99. A higher score indicates stronger dividend sustainability based on payout coverage, growth history, and financial health. This is for informational purposes only and does not constitute investment advice.

SAN.PA

Sanofi SA

€74.07

+€0.54 (+0.73%)

Price history

Key metrics

Sanofi SA has paid a dividend for 37 consecutive years and currently yields 5.52%, above its five year average. Its payout ratio is 64%. Dividend Health rates it Very safe at 85 out of 99, with high confidence.

Data as of 22 Sept 2026

Yield5.52%€4.12 a share

Growth 5y+5.2% a yeara year, five years

Streak37 yearsconsecutive years paid

ValuationUndervalued13.20× earnings, GAAP

P/E ratio, GAAP13.20×

Forward P/E8.16×

Market cap€88.74B

Volume1.5M

Avg. volume1.7M

Beta0.28

Day range€73.74 – 74.70

52W range€71.25 – 91.15

Next dividend

Per share

€4.12

Frequency

Final

Estimated

Declared
—
Ex-date
12 May 2027
in 232 days
Pay date
14 May 2027
estimated

Dividend health

85of 99Very safe

V. riskyVery riskyRiskyRiskyBorder.BorderlineSafeSafeV. safeVery safe

Confidence High · Defensive profile · as of 22 Sept 2026

Total return

Invested 10 years ago€10,000

Worth today€16,603

From price€1,096

From dividends€5,507

€10,000 invested is €16,603 today: €1,096 from the share price and €5,507 from dividends reinvested.

Total return +66.03%. Price alone returned +10.96% over the same window.

Assumes every dividend is reinvested on its ex-dividend date, before tax and dealing costs.

How it compares

Ticker	Health	Valuation	Payout
AZN.LSE AstraZeneca PLC	88	Undervalued	49%
NOVN.SW Novartis AG	81	Overvalued	63%
PFE.US Pfizer Inc	55	Overvalued	126%
GSK.LSE GSK plc	80	Overvalued	50%
BMY.US Bristol-Myers Squibb Company	81	Undervalued	73%
MRK.US Merck & Company Inc	71	Overvalued	47%

Peers that trade most like this stock over the past 3 years.

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

ExchangePA

CurrencyEUR

CountryFR

SectorHealthcare

IndustryDrug Manufacturers - General

ISINFR0000120578

Fiscal year endDecember

Employees74,846

Headquarters46, avenue de la Grande ArmEe, Paris, France, 75017

Dividend data hand-checked against company filings on 14 Sept 2026

Annual DPS€4.12

Yield5.52%

5Y DGR+5.18%

10Y DGR+3.47%

20Y DGR+5.11%

Growth Streak31 yrs

Consecutive Yrs37 yrs

Dividend health85

Annual DPS€4.12

Yield5.52%

5Y DGR+5.18%

10Y DGR+3.47%

20Y DGR+5.11%

Growth Streak31 yrs

Consecutive Yrs37 yrs

Dividend health85

Annual dividends per share

Dividends paid in EUR · based on SAN.PA's fiscal years ending in December

Dividend Policy

Au vu de sa situation financière et de ses résultats opérationnels, Sanofi entend continuer à verser des dividendes annuels.

Source: Investor Relations

Dividend History

Ex-Date	Pay Date	Fiscal Year	Amount	Frequency	Status
12 May 272027-05-12	2027-05-14	FY2026	€4.1200	Final	Estimated
05 May 262026-05-05	2026-05-07	FY2025	€4.1200	Final	Paid
12 May 252025-05-12	2025-05-14	FY2024	€3.9200	Final	Paid
13 May 242024-05-13	2024-05-15	FY2023	€3.7600	Final	Paid
30 May 232023-05-30	2023-06-01	FY2022	€3.5600	Final	Paid
06 May 222022-05-06	2022-05-10	FY2021	€3.3300	Final	Paid
05 May 212021-05-05	2021-05-07	FY2020	€3.2000	Final	Paid
04 May 202020-05-04	2020-05-06	FY2019	€3.1500	Final	Paid
09 May 192019-05-09	2019-05-13	FY2018	€3.0700	Final	Paid
11 May 182018-05-11	2018-05-15	FY2017	€3.0300	Final	Paid
16 May 172017-05-16	2017-05-18	FY2016	€2.9600	Final	Paid
10 May 162016-05-10	2016-05-12	FY2015	€2.9300	Final	Paid
11 May 152015-05-11	2015-05-13	FY2014	€2.8500	Final	Paid
12 May 142014-05-12	2014-05-15	FY2013	€2.8000	Final	Paid
09 May 132013-05-09	2013-05-14	FY2012	€2.7700	Final	Paid
10 May 122012-05-10	2012-05-12	FY2011	€2.6500	Final	Paid
16 May 112011-05-16	2011-05-18	FY2010	€2.5000	Final	Paid
20 May 102010-05-20	2010-05-22	FY2009	€2.4000	Final	Paid
23 Apr 092009-04-23	2009-04-25	FY2008	€2.2000	Annual	Paid
16 May 082008-05-16	2008-05-18	FY2007	€2.0700	Final	Paid
07 Jun 072007-06-07	2007-06-09	FY2006	€1.7500	Annual	Paid
07 Jun 062006-06-07	2006-06-09	FY2005	€1.5200	Annual	Paid
07 Jun 052005-06-07	2005-06-09	FY2004	€1.2000	Annual	Paid
30 Sept 042004-09-30	2004-10-02	FY2003	€0.0497	Annual	Paid
05 May 042004-05-05	2004-05-07	FY2003	€0.9647	Final	Paid
02 Jun 032003-06-02	2003-06-04	FY2002	€0.8400	Annual	Paid
03 Jun 022002-06-03	2002-06-05	FY2001	€0.6600	Annual	Paid
01 Jun 012001-06-01	2001-06-03	FY2000	€0.4400	Annual	Paid
05 Jun 002000-06-05	2000-06-07	FY1999	€0.3200	Annual	Paid
19 May 991999-05-19	1999-05-21	FY1998	€0.2782	Final	Paid
05 Jun 981998-06-05	1998-06-07	FY1997	€0.2653	Annual	Paid
18 Jun 971997-06-18	1997-06-20	FY1996	€0.2502	Annual	Paid
18 Jun 961996-06-18	1996-06-20	FY1995	€0.2388	Annual	Paid
15 Jun 951995-06-15	1995-06-17	FY1994	€0.2068	Annual	Paid
09 Jun 941994-06-09	1994-06-11	FY1993	€0.2068	Annual	Paid
03 Jun 931993-06-03	1993-06-05	FY1992	€0.2068	Annual	Paid
05 Jun 921992-06-05	1992-06-07	FY1991	€0.1981	Annual	Paid
10 Jun 911991-06-10	1991-06-12	FY1990	€0.1853	Annual	Paid
08 Jun 901990-06-08	1990-06-10	FY1989	€0.1800	Annual	Paid

This page is for informational purposes only and does not constitute investment advice. Past dividend payments are not a guarantee of future payments. All data is sourced from public market data and may be delayed. Always do your own research before making any investment decisions.

Your dividend income, mapped.

Free for up to 25 holdings. No credit card. Import your first portfolio in under a minute.

Get started free